Matthew Schlumbrecht

Author

Sylvester Comprehensive Cancer Center ORCID

Also Known As

M SCHLUMBRECHT, M Schlumbrecht, M. P. Schlumbrecht, M. Schlumbrecht, M.P. Schlumbrecht, Matthew Schlumbrecht, Matthew P Schlumbrecht, Matthew P. Schlumbrecht, Matthew Schlumbrecht, Matthew Schlumbrecht, MD

247

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Sylvester Comprehensive Cancer Center University of Miami The University of Texas MD Anderson Cancer Center Banner MD Anderson Cancer Center Massachusetts General Hospital

About

Matthew Schlumbrecht is an author at Sylvester Comprehensive Cancer Center specializing in medicine, obstetrics, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	726
2	Public Health	8	8	167
3	Health Sciences	3	3	441
4	Social Sciences	3	3	84
5	Education	1	1	35

Matthew Schlumbrecht

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study Robert L. Coleman, Domenica Lorusso, Christine Gennigens, The Lancet Oncology Tisotumab VedotinCervical CancerMetastatic Cervical CancerMedicineClinical Trials	2021	367
Rate of vaginal cuff separation following laparoscopic or robotic hysterectomy Alpa M. Nick, J Lange, Michael Frumovitz, Gynecologic Oncology Gynecologic SurgeryLaparoscopyRobotic TechnologyMinimally Invasive ProcedureGynecology	2010	84
Pericytoma With t(7;12) and ACTB-GLI1 Fusion Darcy A. Kerr, André Pinto, Ty K. Subhawong, The American Journal of Surgical Pathology	2019	69
Gene Sequencing for Pathogenic Variants Among Adults With Breast and Ovarian Cancer in the Caribbean Sophia George, Talia Donenberg, Cheryl Alexis, JAMA Network Open	2021	68
S100A4 mediates endometrial cancer invasion and is a target of TGF-β1 signaling Ran Xie, Matthew Schlumbrecht, Gregory L. Shipley, Laboratory Investigation Tumor BiologyEndometrial Cancer InvasionSignaling PathwayMedicineCancer Growth	2009	54
Web‐based LGBT cultural competency training intervention for oncologists: Pilot study results Julia Seay, Amanda Hicks, Merry Jennifer Markham, Cancer	2019	53
A Phase I Trial of Liposomal Doxorubicin, Bevacizumab, and Temsirolimus in Patients with Advanced Gynecologic and Breast Malignancies John W. Moroney, Matthew Schlumbrecht, Thorunn Helgason, Clinical Cancer Research	2011	51
Clinicodemographic factors influencing outcomes in patients with low‐grade serous ovarian carcinoma Matthew Schlumbrecht, Charlotte C. Sun, Karen N. Wong, Cancer	2011	47
Molecular clustering based on ERα and EIG121 predicts survival in high-grade serous carcinoma of the ovary/peritoneum Matthew Schlumbrecht, Su-Su Xie, Gregory L. Shipley, Modern Pathology Tumor HeterogeneityHigh-grade Serous CarcinomaPathologyCancer GenomicsCancer Genetics	2010	40
Factors Associated With Unmet Supportive Care Needs and Emergency Department Visits and Hospitalizations in Ambulatory Oncology Frank J. Penedo, Akina Natori, Sara E. Fleszar‐Pavlović, JAMA Network Open	2023	40

Page 1